Results 171 to 180 of about 384,572 (335)

Impact of Asymptomatic Intracranial Hemorrhage on Outcome After Endovascular Stroke Treatment

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Endovascular treatment (EVT) achieves high rates of recanalization in acute large‐vessel occlusion (LVO) stroke, but functional recovery remains heterogeneous. While symptomatic intracranial hemorrhage (sICH) has been well studied, the prognostic impact of asymptomatic intracranial hemorrhage (aICH) after EVT is less certain ...
Shihai Yang, Chengsong Yue, Zhuang Li, Xiaolei Shi, Haoxuan Zhu, Jie Yang, Linyu Li, Jiaxing Song, Shitao Fan, Gaoming Li, Wenzhe Sun, Zhixian Ye, Jiacheng Huang, Dahong Yang, Jinfu Ma, Xu Xu, Zhixi Wang, Lilan Wang, Guojian Liu, Fengli Li, Changwei Guo, Li Qi, Wenjie Zi   +22 more
wiley   +1 more source

Frequent Allelic Loss at 7p14‐15 Associated with Aggressive Histologic Types of Breast Cancer [PDF]

, 1998
Keisuke Kurose, Aritoshi Iida, Tsutomu Araki, Goi Sakamoto, Fujio Kasumi, Yusuke Nakamura, Mitsuru Emi   +6 more
openalex   +1 more source

Data from Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas

, 2023
M. Nieves Calvo-Vidal, Nahuel Zamponi, Jan Krumsiek, Max A. Stockslager, María V. Revuelta, Jude M. Phillip, Rossella Marullo, Ekaterina N. Tikhonova, Nikita Kotlov, Jayeshkumar Patel, Shao Ning Yang, Lucy Yang, Tony Taldone, Catherine Thieblemont, John P. Leonard, P. G. Martin, Giorgio Inghirami, Gabriela Chiosis, Scott R. Manalis, Leandro Cerchietti   +19 more
openalex   +1 more source

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

Emotional Intelligence and Aggressive Behaviour in Childhood and Adolescence ̶ An Overview of Studies

Psychological Topics, 2017
The purpose of this work was to review research about the development of emotional intelligence (EI) and aggressiveness during childhood and adolescence as well as to review studies that looked into the relationship between these constructs during that ...
Ana Babić Čikeš
doaj  

Aggressive Angiomyxoma [PDF]

Medical Journal Armed Forces India, 2007
S, Rudra, R N, Banerji, N S, Mani
openaire   +2 more sources

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

Arthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

Revisiting the impact of BRCA1 pathogenic variants on the aggressiveness of prostate cancer. [PDF]

JNCI Cancer Spectr
Sasagawa H, Narita S, Matsuda K, Kosaka T, Momozawa Y.   +4 more
europepmc   +1 more source

Treatment of Aggressive Pituitary Adenomas and Carcinomas – An Overview [PDF]

, 2012
Luis V. Syro, León Darío Ortiz, Fabio Rotondo, Humberto Uribe, Luis C. Penagos, Éva Horváth, Kálmán Kovács   +6 more
openalex   +1 more source

Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease

Arthritis Care &Research, EarlyView.
Objective A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M. Padilla, Robert Lafyatis, Kevin F. Gibson, Christina Morse, Eleanor Valenzi, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman, Jonathan Minden, Robyn Domsic, Yingze Zhang, Daniel J. Kass   +13 more
wiley   +1 more source